Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach
CCR5 inhibition in colorectal cancer patients
CCR5 antagonist, an ally to fight against metastatic colorectal cancer
CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice
CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function
CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury
CCR5 and CXCR3 expression in a case of subcutaneous panniculitis-like T-cell lymphoma
CCR5(+)T-bet(+)FoxP3(+) Effector CD4 T Cells Drive Atherosclerosis
CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function
CCR5小分子拮抗剂结构与抗HIV活性构效关系的研究
CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE(-/-) mice
CCR5抑制性多肽C25P的遗传毒性研究
CCR5膜外一、二环模拟短肽对二甲苯致小鼠耳肿胀抑制作用的研究
CCR5-and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic
CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques
CCR5 Mediates Pro-osteoclastic and Osteoclastogenic Leukocyte Chemoattraction
CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
CCR5 and HIV infection
CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
CCR5 on the NK Cells and its Ligand (RANTES) Expressions are Disrupted in South-Eastern Iranian Patients With Chronic Hepatitis B Infection
CCR5 32 mutation is not prevalent in Iranians with chronic HBV infection
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
CCR5 Deficiency Does Not Reduce Hypertensive End-Organ Damage in Mice
CCR5 inhibitors: emergence, success, and challenges
CCR5 knockout strategies ... A way toward HIV cure?
CCR5 Gene Editing of Resting CD4(+) T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice
CCR5 Blockade Promotes M2 Macrophage Activation and Improves Locomotor Recovery After Spinal Cord Injury in Mice
CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines
CCR5 interactions with the variable 3 loop of gp120
CCR5 Expression Is Reduced in Lymph Nodes of HIV Type 1-Infected Women, Compared With Men, But Does Not Mediate Sex-Based Differences in Viral Loads
CCR5 Expression Is Elevated on Endocervical CD4+T Cells in Healthy Postmenopausal Women
CCR5 Is Required for Regulation of Alloreactive T-Cell Responses to Single Class II MHC-Mismatched Murine Cardiac Grafts
CCR5 polymorphism and plague resistance in natural populations of the black rat in Madagascar
CCR5 Delta 32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5 Delta 32 Homozygous Individual
CCR5 Plays a Critical Role in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Both Macrophage Recruitment and M1/M2 Status
CCR5 deficiency induces astrocyte activation, A beta deposit and impaired memory function
CCR5 Deficiency Aggravates Crescentic Glomerulonephritis in Mice
CCR5 Delta 32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5 Delta 32 protective effects
CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation
CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway
CCR5 Delta 32 genotype is associated with outcome in type 2 diabetes mellitus
CCR5 Chemokine Receptor Polymorphism in Patients With HIV-1 From Western India
CCR5: From Natural Resistance to a New Anti-HIV Strategy
CCR5 small interfering RNA ameliorated joint inflammation in rats with adjuvant-induced arthritis
CCR5del32 polymorphism is a protective factor in non-ischemic cardiomyopathy
CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells
CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice (Retraction of vol 157, pg 437, 2009)
CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice (vol 157, pg 437, 2009)
CCR5-, DC-SIGN-dependent endocytosis and delayed reverse transcription after human immunodeficiency virus type 1 infection in human astrocytes
CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
CCR5 Antagonists in the Treatment of HIV-Infected Persons: Is Their Cancer Risk Increased, Decreased, or Unchanged?
CCR5 mediates specific migration of Toxoplasma gondii-primed CD8(+) lymphocytes to inflammatory intestinal epithelial cells
CCR5 deficiency decreases susceptibility to experimental cerebral malaria
CCR5 regulates high dose oral tolerance by modulating CC chemokine ligand 2 levels in the GALT
CCR5 Delta 32 and the genetic susceptibility to rheumatoid arthritis in admixed populations: a multicentre study
CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
CCR5 expression in inflammatory bowel disease and its correlation with inflammatory cells and beta-arrestin2 expression
CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3
CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor
CCR5 and HIV infection, a view from Brussels
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection
CCR5 limits cortical viral loads during West Nile virus infection of the central nervous system
CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma
CCR5 Is Involved in Interruption of Pregnancy in Mice Infected with Toxoplasma gondii during Early Pregnancy
CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV
CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection
CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity
CCR5-edited gene therapies for HIV cure: Closing the door to viral entry
CCR5 Directs the Mobilization of CD11b(+)Gr1(+)Ly6C(low) Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Developmen
CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells
CCR5 Delta 32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study
CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis
CCR5 Deficiency Mitigates the Deleterious Effects of Tumor Necrosis Factor alpha Antagonism in Murine Histoplasmosis
CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virologic failure?
CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations
CCR5 Delta 32 Genotype Leads to a Th2 Type Directed Immune Response in ESRD Patients
CCR5+CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV
CCR5-Delta 32 gene polymorphism is related to celiac disease and autoimmune thyroiditis coincidence in patients with type 1 diabetes
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
CCR5-Delta 32 gene polymorphism is associated with retinopathy in patients with type 1 diabetes